Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-086746

Options or other derivatives

  • Director acquired 7,095 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tullman Stephen A. Director 2015-12-18 Grant or award · Stock option (right to buy) +7,095 7,095 D
Loading xslF345X03/doc4.xml…